Jonathan Akehurst
Corporate Officer/Principal chez Clearstream Technologies Group Ltd.
Profil
Jonathan Akehurst is currently working as a Commercial Manager at Clearstream Technologies Group Ltd.
He previously worked as the President & Chief Executive Officer at Cappella, Inc.
Postes actifs de Jonathan Akehurst
| Sociétés | Poste | Début |
|---|---|---|
Clearstream Technologies Group Ltd.
 Clearstream Technologies Group Ltd. Medical SpecialtiesHealth Technology Clearstream Technologies Group develops and manufactures medical devices. It develops, manufactures and markets medical devices used by interventional cardiologists, radiologists, and vascular surgeons in angioplasty procedures. The company was founded in 1996 and is headquartered in Enniscorthy, Ireland. | Corporate Officer/Principal | 01/02/2009 |
Anciens postes connus de Jonathan Akehurst
| Sociétés | Poste | Fin |
|---|---|---|
Cappella, Inc.
 Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Clearstream Technologies Group Ltd.
Clearstream Technologies Group Ltd. Medical SpecialtiesHealth Technology Clearstream Technologies Group develops and manufactures medical devices. It develops, manufactures and markets medical devices used by interventional cardiologists, radiologists, and vascular surgeons in angioplasty procedures. The company was founded in 1996 and is headquartered in Enniscorthy, Ireland. | Health Technology |
Cappella, Inc.
Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Health Technology |
